LivingGLP1
Study S003402

Comparison of the Beta Cell Mass During and Shortly After the Honeymoon Phase of Type 1 Diabetes Using Gallium-68-exendin PET

Registration

Registration
NCT03917238
Acronym
Honeymoon
Study type
INTERVENTIONAL
Masking
NONE
Status
ACTIVE_NOT_RECRUITING
Enrollment
14
Start
2019-10-11
Primary completion
2026-11-25
Lead sponsor
Radboud University Medical Center
Conditions
Type 1 Diabetes Mellitus
Interventions
RADIATION:gallium-68-exendin injection followed by PET/CT scan
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Pancreatic uptake of gallium-68-NODAGA-exendin-4 [2 years]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.